Taurine attenuates bilirubin-induced neurotoxicity in the auditory system in neonatal guinea pigs

International Journal of Pediatric Otorhinolaryngology

Volumn 77, Issue 5, 2013, Pages 647-654

  Ye, Hai Bo ^a   Wang, Jian ^a,b   Zhang, Wei Tian ^a   Shi, Hai Bo ^a   Yin, Shan Kai ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Auditory nerve; Bilirubin; Cochlea; Guinea pigs; Neurotoxicity

Indexed keywords

BILIRUBIN; TAURINE;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ELECTROCOCHLEOGRAPHY; EVOKED BRAIN STEM AUDITORY RESPONSE; FEMALE; GUINEA PIG; HAIR CELL; HEARING; IN VIVO STUDY; LATENT PERIOD; MALE; NERVE CELL LESION; NERVE FIBER; NEUROTOXICITY; NEWBORN; NEWBORN JAUNDICE; NONHUMAN; ONSET AGE; OTOTOXICITY; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; SENSORY NERVE; SPIRAL GANGLION;

ANIMALS; AUDIOMETRY, EVOKED RESPONSE; BILIRUBIN; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; GUINEA PIGS; HAIR CELLS, AUDITORY, INNER; HUMANS; HYPERBILIRUBINEMIA; INFANT, NEWBORN; NEURONS; NEUROTOXICITY SYNDROMES; TAURINE;

EID: 84876744218     PISSN: 01655876     EISSN: 18728464     Source Type: Journal    
DOI: 10.1016/j.ijporl.2012.11.037     Document Type: Article

References (48)

1. Maisels M.J., McDonagh A.F. Phototherapy for neonatal jaundice. N. Engl. J. Med. 2008, 358(February (9)):920-928.
2. Bhutani V.K., Johnson L.H., Keren R. Diagnosis and management of hyperbilirubinemia in the term neonate: for a safer first week. Pediatr. Clin. North Am. 2004, 51(August (4)):843-861. vii.
3. Watson R.L. Hyperbilirubinemia. Crit. Care Nurs. Clin. North Am. 2009, 21(March (1)):97-120. vii.
4. Ostrow J.D., Pascolo L., Brites D., Tiribelli C. Molecular basis of bilirubin-induced neurotoxicity. Trends Mol. Med. 2004, 10(February (2)):65-70.
5. Wennberg R.P., Ahlfors C.E., Bhutani V.K., Johnson L.H., Shapiro S.M. Toward understanding kernicterus: a challenge to improve the management of jaundiced newborns. Pediatrics 2006, 117(February (2)):474-485.
6. Watchko J.F. Kernicterus and the molecular mechanisms of bilirubin-induced CNS injury in newborns. Neuromol. Med. 2006, 8(4):513-529.
7. Ostrow J.D., Pascolo L., Shapiro S.M., Tiribelli C. New concepts in bilirubin encephalopathy. Eur. J. Clin. Invest. 2003, 33(November (11)):988-997.
8. Ahdab-Barmada M., Moossy J. The neuropathology of kernicterus in the premature neonate: diagnostic problems. J. Neuropathol. Exp. Neurol. 1984, 43(January (1)):45-56.
9. Dubin W. Neurological lesions in erythroblastosis fetails in relation to nuclear deafness. Am. J. Clin. Pathol. 1951, (21):935-939.
10. Soorani-Lunsing I., Woltil H.A., Hadders-Algra M. Are moderate degrees of hyperbilirubinemia in healthy term neonates really safe for the brain?. Pediatr. Res. 2001, 50(December (6)):701-705.
11. Ye H.B., Shi H.B., Wang J., Ding D.L., Yu D.Z., Chen Z.N., et al. Bilirubin induces auditory neuropathy in neonatal guinea pigs via auditory nerve fiber damage. J. Neurosci. Res. 2012, 90(November (11)):2201-2213.
12. Shapiro S.M. Bilirubin toxicity in the developing nervous system. Pediatr. Neurol. 2003, 29(November (5)):410-421.
13. Wilkinson A.R., Jiang Z.D. Brainstem auditory evoked response in neonatal neurology. Semin Fetal Neonatal Med. 2006, 11(December (6)):444-451.
14. Harding N.J., Davies W.E. Cellular localisation of taurine in the organ of Corti. Hear. Res. 1993, 65(February (1-2)):211-215.
15. Jacobsen J.G., Smith L.H. Biochemistry and physiology of taurine and taurine derivatives. Physiol. Rev. 1968, 48(April (2)):424-511.
16. Chen W.Q., Jin H., Nguyen M., Carr J., Lee Y.J., Hsu C.C., et al. Role of taurine in regulation of intracellular calcium level and neuroprotective function in cultured neurons. J. Neurosci. Res. 2001, 66(November (4)):612-619.
17. El Idrissi A., Trenkner E. Growth factors and taurine protect against excitotoxicity by stabilizing calcium homeostasis and energy metabolism. J. Neurosci. 1999, 19(November (21)):9459-9468.
18. Saransaari P., Oja S.S. Taurine and neural cell damage. Amino Acids 2000, 19(3-4):509-526.
19. Okamoto K., Kimura H., Sakai Y. Taurine-induced increase of the Cl-conductance of cerebellar Purkinje cell dendrites in vitro. Brain Res. 1983, 259(January (2)):319-323.
20. Taber K.H., Lin C.T., Liu J.W., Thalmann R.H., Wu J.Y. Taurine in hippocampus: localization and postsynaptic action. Brain Res. 1986, 386(October (1-2)):113-121.
21. Chen X.C., Pan Z.L., Liu D.S., Han X. Effect of taurine on human fetal neuron cells: proliferation and differentiation. Adv. Exp. Med. Biol. 1998, 442:397-403.
22. Sturman J.A. Taurine in development. Physiol. Rev. 1993, 73(January (1)):119-147.
23. Lombardini J.B. Effects of taurine on calcium ion uptake and protein phosphorylation in rat retinal membrane preparations. J. Neurochem. 1985, 45(July (1)):268-275.
24. Wu H.J.Y., Wei J., Jin H., Sha D., Wu J.Y. Mode of action of taurine as a neuroprotector. Brain Res. 2005, 1038:123-131.
25. Zhang B., Yang X., Gao X. Taurine protects against bilirubin-induced neurotoxicity in vitro. Brain Res. 2010, 1320(March):159-167.
26. Grojean S., Koziel V., Vert P., Daval J.L. Bilirubin induces apoptosis via activation of NMDA receptors in developing rat brain neurons. Exp. Neurol. 2000, 166(December (2)):334-341.
27. McDonald J.W., Shapiro S.M., Silverstein F.S., Johnston M.V. Role of glutamate receptor-mediated excitotoxicity in bilirubin-induced brain injury in the Gunn rat model. Exp. Neurol. 1998, 150(March (1)):21-29.
28. Hoffman D.J., Zanelli S.A., Kubin J., Mishra O.P., Delivoria-Papadopoulos M. The in vivo effect of bilirubin on the N-methyl-d-aspartate receptor/ion channel complex in the brains of newborn piglets. Pediatr. Res. 1996, 40(December (6)):804-808.
29. Johnston M.V. Excitotoxicity in perinatal brain injury. Brain Pathol. 2005, 15(July (3)):234-240.
30. Haustein M.D., Read D.J., Steinert J.R., Pilati N., Dinsdale D., Forsythe I.D. Acute hyperbilirubinaemia induces presynaptic neurodegeneration at a central glutamatergic synapse. J. Physiol. 2010, 588(December (Pt 23)):4683-4693.
31. Brito M.A., Vaz A.R., Silva S.L., Falcão A.S., Fernandes A., Silva R.F., et al. N-methyl-aspartate receptor and neuronal nitric oxide synthase activation mediate bilirubin-induced neurotoxicity. Mol. Med. 2010, 16(September-October (9-10)):372-380.
32. Li C.Y., Shi H.B., Song N.Y., Yin S.K. Bilirubin enhances neuronal excitability by increasing glutamatergic transmission in the rat lateral superior olive. Toxicology 2011, 284(June (1-3)):19-25.
33. Johnston M.V., Hoon A.H. Possible mechanisms in infants for selective basal ganglia damage from asphyxia, kernicterus, or mitochondrial encephalopathies. J. Child Neurol. 2000, 15(September (9)):588-591.
34. Liu H.Y., Chi F.L., Gao W.Y. Taurine modulates calcium influx under normal and ototoxic conditions in isolated cochlear spiral ganglion neurons. Pharmacol. Rep. 2008, 60(July-August (4)):508-513.
35. Schaffer S., Azuma J., Takahashi K., Mozaffari M. Why is taurine cytoprotective?. Adv. Exp. Med. Biol. 2003, 526:307-321.
36. Wu J.Y., Prentice H. Role of taurine in the central nervous system. J. Biomed. Sci. 2010, 17(Suppl. 1):S1.
37. Shi H.B., Kakazu Y., Shibata S., Matsumoto N., Nakagawa T., Komune S. Bilirubin potentiates inhibitory synaptic transmission in lateral superior olive neurons of the rat. Neurosci. Res. 2006, 55(June (2)):161-170.
38. Gao X., Yang X., Zhang B. Neuroprotection of taurine against bilirubin-induced elevation of apoptosis and intracellular free calcium ion in vivo. Toxicol. Mech. Methods 2011, 21(June (5)):383-387.
39. Song N.Y., Shi H.B., Li C.Y., Yin S.K. Interaction between taurine and GABA(A)/glycine receptors in neurons of the rat anteroventral cochlear nucleus. Brain Res. 2012, 1472(September):1-10.
40. Wu J.Y., Wu H., Jin Y., Wei J., Sha D., Prentice H., et al. Mechanism of neuroprotective function of taurine. Adv. Exp. Med. Biol. 2009, 643:169-179.
41. Bianchi L., Colivicchi M.A., Ballini C., Fattori M., Venturi C., Giovannini M.G., et al. Taurine, taurine analogues, and taurine functions: overview. Adv. Exp. Med. Biol. 2006, 583:443-448.
42. Wu H., Jin Y., Wei J., Jin H., Sha D., Wu J.Y. Mode of action of taurine as a neuroprotector. Brain Res. 2005, 1038(March (2)):123-131.
43. Pan C., Prentice H., Price A.L., Wu J.Y. Beneficial effect of taurine on hypoxia- and glutamate-induced endoplasmic reticulum stress pathways in primary neuronal culture. Amino Acids 2012, 43(August (2)):845-855.
44. Angelini E., Teixeira M., Aran J.M., Ferrary E. Taurine entry into perilymph of the guinea pig. Eur. Arch. Otorhinolaryngol. 1998, 255(7):331-333.
45. Wojcik O.P., Koenig K.L., Zeleniuch-Jacquotte A., Costa M., Chen Y. The potential protective effects of taurine on coronary heart disease. Atherosclerosis 2010, 208(January (1)):19-25.
46. Hayes K.C., Carey R.E., Schmidt S.Y. Retinal degeneration associated with taurine deficiency in the cat. Science 1975, 188(May (4191)):949-951.
47. Schaffer S.W., Czarnecki C.M., Cawthray M., Chovan J.P. Cardiac taurine levels and sarcolemmal calcium binding activity in furazolidone-induced cardiomyopathy. Comp. Biochem. Physiol. C 1981, 69C(1):149-151.
48. Pion P.D., Kittleson M.D., Rogers Q.R., Morris J.G. Myocardial failure in cats associated with low plasma taurine: a reversible cardiomyopathy. Science 1987, 237(August (4816)):764-768.